David Yocum
- Pirfenidone post-authorization safety registry (PASSPORT) – Interim analysis of IPF treatmentBy Dirk Koschel, Vincent Cottin, Magnus Skold, Sara Tomassetti, Arata Azuma, Christophe Giot, David Yocum, Sundos Hamza and Toby M. MaherDirk Koschel1Respiratory Medicine, Fachkrankenhaus Coswig, Coswig, Saxony, GermanyVincent Cottin2Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Lyon 1 University, Lyon, FranceMagnus Skold3Medicine Solna, Karolinska Institutet, Stockholm, SwedenSara Tomassetti4Diseases of the Thorax, GB Morgagni Hospital, Forli, FC, ItalyArata Azuma5Post-graduate School of Medicine, Pulmonary Medicine, Nippon Medical School, Tokyo, JapanChristophe Giot6Medical Sciences EU, InterMune, Inc., Muttenz, BL, SwitzerlandDavid Yocum7Drug Safety Risk Management, InterMune, Inc., Brisbane, CA,Sundos Hamza7Drug Safety Risk Management, InterMune, Inc., Brisbane, CA,Toby M. Maher8Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.